skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Treatment of tumors with genetically engineered herpes virus

Patent ·
OSTI ID:1080289

Disclosed are methods for treating cancer by administering an effective amount of a modified Herpes simplex virus.

Research Organization:
University of Alabama Research Foundation
Sponsoring Organization:
USDOE
DOE Contract Number:
FG05-93ER61654
Assignee:
Arch Development Corporation (Chicago, IL); UAB Research Foundation (Birmingham, AL)
Patent Number(s):
8,318,691
Application Number:
12/802,443
OSTI ID:
1080289
Country of Publication:
United States
Language:
English

References (106)

In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020. II. Studies in Immunocompetent and Immunosuppressed Owl Monkeys (Aotus trivirgatus) journal August 1990
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. journal January 1985
Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation. journal May 1991
Programmed cell death: Apoptosis and oncogenesis journal June 1991
Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha- and beta-regulated gene chimeras. journal September 1984
Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation journal May 1998
Herpes simplex virus neurovirulence and productive infection of neural cells is associated with a function which maps between 0.82 and 0.832 map units on the hsv genome journal October 1989
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents journal June 1997
Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence journal March 1991
Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis journal February 1991
Sequences of the bovine herpesvims 1 homologue of herpes simplex virus type-1 α-trans-inducing factor (UL48) journal October 1992
Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment. journal January 1985
Sequence of MyD116 cDNA: a novel myeloid differentiation primary response gene induced by IL6 journal January 1990
Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells journal December 1997
Transfer of Genes to Humans: Early Lessons and Obstacles to Success journal October 1995
The Herpes Simplex Virus Type 2 (HG52) Variant JH2604 Has a 1488 bp Deletion which Eliminates Neurovirulence in Mice journal November 1989
Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus DNA. journal January 1986
Structural features of the herpes simplex virus alpha gene 4, 0, and 27 promoter-regulatory sequences which confer alpha regulation on chimeric thymidine kinase genes. journal January 1982
The DNA Sequences of the Long Repeat Region and Adjoining Parts of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1 journal November 1988
Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. journal June 1993
Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies. journal January 1984
The basic science of gene therapy journal May 1993
Cloning of reiterated and nonreiterated herpes simplex virus 1 sequences as BamHI fragments. journal July 1980
Size, Composition, and Structure of the Deoxyribonucleic Acid of Herpes Simplex Virus Subtypes 1 and 2 journal January 1971
The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency journal September 1991
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins journal January 1998
Why do neurons die when deprived of trophic factor? journal September 1989
In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020: Construction and Evaluation in Rodents journal September 1988
A noninverting genome of a viable herpes simplex virus 1: presence of head-to-tail linkages in packaged genomes and requirements for circularization after infection. journal January 1985
Mapping of functional and antigenic domains of the alpha 4 protein of herpes simplex virus 1. journal January 1988
Restoration of Wild-type Pathogenicity to an Attenuated DNA Polymerase Mutant of Herpes Simplex Virus Type 1 journal November 1986
Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. journal October 1991
Serial passage of embryonic human astrocytes in serum-free, hormone-supplemented medium journal January 1991
Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS. journal January 1986
p53 status and the efficacy of cancer therapy in vivo journal November 1994
Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA journal November 1982
Characterization of Herpes Simplex Virus Strains Differing in their Effects on Social Behaviour of Infected Cells journal May 1968
2021 Enhanced replication of attenuated HSV-1 in irradiated human glioma xenografts journal January 1997
Cell suicide: by ICE, not fire journal February 1994
The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1 journal July 1988
Vaccine potential of a live avirulent herpes simplex virus journal August 1986
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors journal June 1992
Characterization of a viable, noninverting herpes simplex virus 1 genome derived by insertion and deletion of sequences at the junction of components L and S. journal May 1983
Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of herpes simplex virus 1. journal November 1995
Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors journal February 1998
Application of Denatured, Electrophoretically Separated, and Immobilized Lysates of Herpes Simplex Virus-Infected Cells for Detection of Monoclonal Antibodies and for Studies of the Properties of Viral Proteins journal January 1983
Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences journal July 1985
Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1 journal January 1986
Enhancement of Gene Therapy Specificity for Diffuse Colon Carcinoma Liver Metastases with Recombinant Herpes Simplex Virus journal January 1996
Site-specific cleavage/packaging of herpes simplex virus DNA and the selective maturation of nucleocapsids containing full-length viral DNA journal March 1982
p53 mutations in human cancers journal July 1991
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis journal July 1991
The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. journal October 1996
Prevention of vertebrate neuronal death by the crmA gene journal February 1994
Experimental therapy of human glioma by means of a genetically engineered virus mutant journal May 1991
A Variant of Herpes Simplex Virus Type 2 Strain HG52 with a 1.5 kb Deletion in RL between 0 to 0.02 and 0.81 to 0.83 Map Units Is Non-neurovirulent for Mice journal March 1989
The Fas death factor journal March 1995
What is the Optimal Rodent Model for Anti-tumor Drug Testing? journal September 1998
Herpes simplex virus 1 RNA-binding protein US11 negatively regulates the accumulation of a truncated viral mRNA. journal January 1991
Transmission of Herpes-Simplex Virus type 1 in a Nursery for the Newborn Identification of Viral Isolates by D.N.A. "Fingerprinting" journal May 1978
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship journal November 1991
The herpes simplex virus 1 gene for ICP34.5, which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17syn+. journal January 1990
Site-specific inversion sequence of the herpes simplex virus genome: Domain and structural features journal November 1981
The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice journal October 1978
Characterization of the IE110 Gene of Herpes Simplex Virus Type 1 journal November 1986
Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent journal November 1983
Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17 journal April 1992
Identification by antibody to a synthetic peptide of a protein specified by a diploid gene located in the terminal repeats of the L component of herpes simplex virus genome. journal January 1986
Prevention of apoptosis by a baculovirus gene during infection of insect cells journal November 1991
A simple method for displaying the hydropathic character of a protein journal May 1982
CANCER MODELS: Systems for Identifying New Drugs Are Often Faulty journal November 1997
Genetic Studies with Herpes Simplex Virus Type 1. The Isolation of Temperature-sensitive Mutants, their Arrangement into Complementation Groups and Recombination Analysis Leading to a Linkage Map journal March 1973
Location and Orientation of Homologous Sequences in the Genomes of Five Herpesviruses journal September 1983
Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions. journal January 1975
Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death journal June 1991
The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells. journal April 1992
Spatial and temporal control of gene therapy using ionizing radiation journal August 1995
A generalized technique for deletion of specific genes in large genomes: a gene 22 of herpes simplex virus 1 is not essential for growth journal July 1981
Inverted Repetitions in the Chromosome of Herpes Simplex Virus journal January 1974
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes journal November 1991
Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus I journal January 1988
Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants. journal January 1978
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells journal October 1996
Isomerization of herpes simplex virus 1 genome: identification of the cis-acting and recombination sites within the domain of the a sequence journal July 1985
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients journal July 1996
DNA sequencing with chain-terminating inhibitors journal December 1977
Infections with Herpes Simplex Viruses journal March 1986
Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components. journal November 1975
The terminal a sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component. journal January 1986
Restitution of the UL56 gene expression of HSV-1 HFEM led to restoration of virulent phenotype; deletion of the amino acids 217 to 234 of the UL56 protein abrogates the virulent phenotype journal January 1996
Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer journal March 1990
Multipotent neural cell lines can engraft and participate in development of mouse cerebellum journal January 1992
Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture journal November 1990
Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. journal February 1995
Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants. journal January 1990
Restriction of Herpes Simplex Virus by Macrophages journal January 1971
Isolation of Latent Herpes Simplex Virus from the Superior Cervical and Vagus Ganglions of Human Beings journal May 1978
Temporal Cluster of Herpes Simplex Encephalitis: Investigation by Restriction Endonuclease Cleavage of Viral DNA journal April 1980
Proteins Specified by Herpes Simplex Virus XI. Identification and Relative Molar Rates of Synthesis of Structural and Nonstructural Herpes Virus Polypeptides in the Infected Cell journal January 1973
Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain journal August 1991
Genetic and biological analyses of a herpes simplex virus intertypic recombinant reduced specifically for neurovirulence. journal January 1987
Mechanisms and genes of cellular suicide journal March 1995
Comparative Sequence Analysis of the Long Repeat Regions and Adjoining Parts of the Long Unique Regions in the Genomes of Herpes Simplex Viruses Types 1 and 2 journal December 1991
Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. journal February 1982
Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence journal November 1983
Gene therapy - promises, problems and prospects journal September 1997

Similar Records

Recombinant herpes simplex virus useful for treating neoplastic disease
Patent · Tue Jun 29 00:00:00 EDT 2010 · OSTI ID:1080289

Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents
Journal Article · Wed Nov 01 00:00:00 EST 1995 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:1080289

Isolation of a protein kinase induced by herpes simplex virus type 1
Journal Article · Wed Apr 01 00:00:00 EST 1981 · J. Virol.; (United States) · OSTI ID:1080289

Related Subjects